Cite
HARVARD Citation
Mouratoglou, S. et al. (2020). Transition protocol from subcutaneous treprostinil to intravenous epoprostenol in deteriorating patients with pulmonary arterial hypertension. International journal of cardiology. pp. 187-189. [Online].